Delivery Order SPE2DB24D1021-SPE2DB24FESEW

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,656.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,255,177 units of Procainamide 1 gram/10 ml vial, with a completion date of February 13, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,140.57, is for the supply of 4561655760 - Procainamide 1 gram/10 ml vial, 10 ml. The contract has an ultimate completion date of August 1, 2023 and was awarded on July 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,209.72, is for the procurement of 4566753882 ! PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML. The contract is a firm fixed-price delivery order with an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.60 firm-fixed-price contract is for the supply of Procainamide 1 gram/10 ml vials, a medication used to treat certain heart rhythm disorders. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,269.62 contract is for the delivery of 4,564,138,129 units of Procainamide 1,000 mg/2 ml vials to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,432.75 firm fixed-price delivery order is for the supply of 4565626834 - Procainamide 1 Gram/10 ML Vial 10ML, a critical pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $2,387.46 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,636,160 units of the drug Procainamide 1,000 mg/10 ml. This contract has a completion date of March 21, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Procainamide 1 gram/10 mL vials. The contract has a firm fixed price of $22,283.88 and an ultimate completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourceberger Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,782,502 units of Procainamide 1 gram/10 ml vials. The contract has a completion date of February 28, 2024 and a potential value of $1,399.16. This award is part of Amerisourceberger's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, to...
This is a federal contract award (SPE2DX15D3026|SPE2DX25FUWFZ) from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,482.97 firm-fixed-price delivery order is for the procurement of 4,567,132,175 units of the drug Procainamide 1 gram/10 mL vial, 10 mL. This award is not designated as a set-aside contract. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a $999,999,999...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FESEW
    Delivery Order

This is a $1,844.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,943,120 units of 1,000 mg/10 ml procainamide vials. The contract has an ultimate completion date of June 20, 2024 and was awarded on June 18, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. Amerisourcebergen has also been awarded an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. The contract does not utilize a set-aside designation.

Generated 11/1/24, 10:18 AM